title: Interleukin-17 inhibition: a route to psoriasis clearance?
authors.affiliation: Department of Dermatology, AP-HP Hôpital Saint-Louis, 75475 Paris Cedex 10, France; Sorbonne Paris Cité Université Paris-Diderot, Paris, France; INSERMU1163, Institut Imagine, Paris, France. Electronic address: herve.bachelez@sls.aphp.fr.
authors.forename: Hervé
authors.initials: H
authors.lastname: Bachelez
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D008297:Male; D011565:Psoriasis / Q000188:drug therapy*; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D061067:Antibodies, Monoclonal, Humanized; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor